Fatty Liver Disease (Non-Alcoholic)
Preclinical study identifies possible therapeutic target for cardiovascular risk factors that avoid the common problem of an increased risk of fatty liver disease.
Basic science research explores the effects of impaired glycine metabolism in nonalcoholic fatty liver disease and how to potentially use glycine-based treatment to help people with NAFLD.
A Michigan Medicine team looks into the prevalence of NAFLD in patients with heart failure with preserved ejection fraction.
Mice lacking E4BP4 were protected against diet’s damaging effects.
A team of experts compared rates of cirrhosis, cardiovascular disease and metabolic abnormalities between patients with fatty liver disease who were of normal weight and overweight or obese.